Cargando…

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation

This study aimed to evaluate the protective effect of chitosan (CS) against hypercholesterolemia (HC) induced arginase activation and disruption of nitric oxide (NO) biosynthesis using erythrocytes as cellular model. Human erythrocytes were isolated and classified into eight groups. Next, cells were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harisa, Gamaleldin I., Attia, Sabry M., Zoheir, Khairy M.A., Alanazi, Fars K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310152/ https://www.ncbi.nlm.nih.gov/pubmed/28223872 http://dx.doi.org/10.1016/j.jsps.2016.05.007

Ejemplares similares

Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer
por: Harisa, Gamaleldin I., et al.
Publicado: (2016)

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study
por: Harisa, Gamaleldin I., et al.
Publicado: (2015)

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs
por: Harisa, Gamaleldin I., et al.
Publicado: (2013)

Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
por: Faris, Tarek M., et al.
Publicado: (2020)

Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells
por: Alhadad, Laila J., et al.
Publicado: (2020)

Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons
por: Harisa, Gamaleldin I., et al.
Publicado: (2023)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer
por: Sherif, Abdelrahman Y., et al.
Publicado: (2023)

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
por: Sherif, Abdelrahman Y., et al.
Publicado: (2022)

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
por: Sherif, Abdelrahman Y, et al.
Publicado: (2022)

Pravastatin Provides Antioxidant Activity and Protection Of Erythrocytes Loaded Primaquine
por: Alanazi, Fars
Publicado: (2010)

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition
por: Alanazi, Saleh A., et al.
Publicado: (2021)

Antiretroviral therapy abrogates association between arginase activity and HIV disease severity()
por: Cloke, T.E., et al.
Publicado: (2010)

Novel Approach Using shRNA of IQGAP1 for Colon Cancer Therapy: HCT116 as a Surrogate Model Colorectal Carcinoma
por: Zoheir, Khairy M A, et al.
Publicado: (2022)

Chitosan-Coated Flexible Liposomes Magnify the Anticancer Activity and Bioavailability of Docetaxel: Impact on Composition
por: Alshraim, Mohammed O., et al.
Publicado: (2019)

The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer
por: Alomrani, Abdullah, et al.
Publicado: (2019)

Hypercholesterolemia-induced increase in plasma oxidized LDL abrogated pro angiogenic response in kidney grafts
por: Kerforne, Thomas, et al.
Publicado: (2019)

Chitosan and blueberry treatment induces arginase activity and inhibits nitric oxide production during acetaminophen-induced hepatotoxicity
por: Ozcelik, Eda, et al.
Publicado: (2014)

THE ABROGATION OF SHEEP ERYTHROCYTE TOLERANCE IN RATS BY MEANS OF THE TRANSFER OF ALLOGENEIC LYMPHOCYTES
por: McCullagh, Peter J.
Publicado: (1970)

Microwave Irradiation-Assisted Synthesis of a Novel Crown Ether Crosslinked Chitosan as a Chelating Agent for Heavy Metal Ions (M(+n))
por: Radwan, Awwad A., et al.
Publicado: (2010)

In vivo influence of extract from Aronia melanocarpa on the erythrocyte membranes in patients with hypercholesterolemia
por: Duchnowicz, Piotr, et al.
Publicado: (2012)

High-level expression of human arginase I in Pichia pastoris and its immobilization on chitosan to produce L-ornithine
por: Zhang, Xue, et al.
Publicado: (2015)

Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box–Behnken Experimental Design
por: Soliman, Noha M., et al.
Publicado: (2022)

Moringa oleifera Root Induces Cancer Apoptosis more Effectively than Leave Nanocomposites and Its Free Counterpart
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2017)

Myrtle berries seeds aqueous extract abrogates chronic alcohol consumption-induced erythrocytes osmotic stability disturbance, haematological and biochemical toxicity
por: Jabri, Mohamed-Amine, et al.
Publicado: (2018)

Arginase and pulmonary diseases
por: Maarsingh, Harm, et al.
Publicado: (2008)

Evaluation of Hemagglutination Activity of Chitosan Nanoparticles Using Human Erythrocytes
por: de Lima, Jefferson Muniz, et al.
Publicado: (2015)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Chitosan and Nano-Chitosan for Management of Harpophora maydis: Approaches for Investigating Antifungal Activity, Pathogenicity, Maize-Resistant Lines, and Molecular Diagnosis of Plant Infection
por: Hassan, Eman O., et al.
Publicado: (2022)

The anticarcinogenic effect of eugenol on lung cancer induced by diethylnitrosamine/2-acetylaminofluorene in Wistar rats: insight on the mechanisms of action
por: Morsy, Hadeer M., et al.
Publicado: (2023)

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017)

Combined Modeling Study of the Binding Characteristics of Natural Compounds, Derived from Psoralea Fruits, to β-Amyloid Peptide Monomer
por: Radwan, Awwad, et al.
Publicado: (2022)

Arginase 2 negatively regulates sorafenib-induced cell death by mediating ferroptosis in melanoma: The role of Arginase 2 in sorafenib-induced ferroptosis in melanoma
por: Yu, Yi, et al.
Publicado: (2022)

Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency
por: Ballantyne, Laurel L., et al.
Publicado: (2016)

Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
por: Lam, Sze-Kwan, et al.
Publicado: (2019)

Metabolomic Analysis of Diverse Mice Reveals Hepatic Arginase-1 as Source of Plasma Arginase in Plasmodium chabaudi Infection
por: Davis, Nicole M., et al.
Publicado: (2021)

Arginase and Arginine Dysregulation in Asthma
por: Benson, Renée C., et al.
Publicado: (2011)

Endothelial arginase II and atherosclerosis
por: Ryoo, Sungwoo, et al.
Publicado: (2011)

Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer
por: Gannon, Philippe O., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bus6ljv80lpvvgvn4116l3b3gf